Vaginal Progesterone effect on pregnancy rate in infertility women with polycystic ovarian syndrome

Phase 2

• Conditions: Polycystic ovarian syndrome; Infertility and Polycystic Ovarian Syndrome.

• Registration Number: IRCT201206072967N4
• Lead Sponsor: Vice chancellor of research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Inclusion criteria consist 20 -35 years, having Rotterdam criteria (having 2 from 3 following criteria: Oligomenorrehea or amenorrhea, polycystic ovaries in sonography, clinical or biochemical evidences of hyperandrogenism). The patient with abnormal hormonal assay in the third day of menstruation (including FSH, TSH, prolactin, 17 Hydroxy progesterone and testosterone), tubal obstruction in HSG or laparoscopy and infertility due to male factor will be excluded.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy. Timepoint: Last day of receiving progesterone suppository. Method of measurement: Blood test.